Pharmaceutical Preparations · DE · CIK 1819133
Tango Therapeutics discovers and develops precision oncology therapies, including novel PRMT5 inhibitors for various cancers
Comparable business profile · signals at a glance
Coverage (30d): 3 reputable articles · skews ▲ positive.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
In the 90 days to Mar 25, 2026: 3 sold $2.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 25, 2026 | Crystal AdamPresident, R&D | Sell | 12,000 | $20.11 | $241K |
| Mar 5, 2026 | Crystal AdamPresident, R&D | Sell | 20,251 | $15.00 | $304K |
| Feb 25, 2026 | Crystal AdamPresident, R&D | Sell | 54,345 | $12.77 | $694K |
| Feb 3, 2026 | Weber BarbaraDirector, Executive Chair | Sell | 30,186 | $12.26 | $370K |
| Feb 3, 2026 | Crystal AdamPresident, R&D | Sell | 18,251 | $12.26 | $224K |
| Feb 3, 2026 | Beckman DaniellaChief Financial Officer | Sell | 10,204 | $12.26 | $125K |
| Feb 3, 2026 | Weber BarbaraDirector, Executive Chair | Sell | 333 | $12.90 | $4K |
| Feb 3, 2026 | Crystal AdamPresident, R&D | Sell | 201 | $12.90 | $3K |
| Feb 3, 2026 | Beckman DaniellaChief Financial Officer | Sell | 113 | $12.90 | $1K |
| Oct 23, 2025 | Trv Gp Iv, LlcTenPercentOwner | Sell | 477,401 | $10.15 | $4.8M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.